Showing results (41-50 of 85) with videos related to
Sort By:
Pageof 9
Journal of Enzyme Inhibition and Medicinal Chemistry|September 30, 2008
Synthesis and antitumour evaluation of novel 2-phenylbenzimidazolesHachemi Kadri, Charles S Matthews, Tracey D Bradshaw, et al.Medchemcomm|August 16, 2018
Rational design and synthesis of novel phenylsulfonyl-benzamides as anti-prostate cancer agentsMarcella Bassetto, Salvatore Ferla, Gilda Giancotti, et al.European Journal of Medicinal Chemistry|July 10, 2019
A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancerFabrizio Pertusati, Salvatore Ferla, Marcella Bassetto, et al.Journal of Medicinal Chemistry|June 23, 2006
Structural studies on bioactive compounds. 40.(1) Synthesis and biological properties of fluoro-, methoxyl-, and amino-substituted 3-phenyl-4H-1-benzopyran-4-ones and a comparison of their antitumor activities with the activities of related 2-phenylbenzothiazolesDavid A Vasselin, Andrew D Westwell, Charles S Matthews, et al.Journal of Cancer|December 21, 2016
The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in CancerJennifer M Wymant, Stephen Hiscox, Andrew D Westwell, et al.Biochemical Pharmacology|October 18, 2003
Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compoundsMonica Pallis, Tracey D Bradshaw, Andrew D Westwell, et al.Journal of Medicinal Chemistry|March 9, 2007
Quinols as novel therapeutic agents. 7.1 Synthesis of antitumor 4-[1-(arylsulfonyl-1H-indol-2-yl)]-4-hydroxycyclohexa-2,5-dien-1-ones by Sonogashira reactionsAndrew J McCarroll, Tracey D Bradshaw, Andrew D Westwell, et al.British Journal of Cancer|June 14, 2017
Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiativeHans R Hendriks, Anne-Sophie Govaerts, Iduna Fichtner, et al.European Journal of Medicinal Chemistry|February 9, 2016
Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cellsSahar Kandil, Jennifer M Wymant, Benson M Kariuki, et al.European Journal of Medicinal Chemistry|February 12, 2019
Discovery of deshydroxy bicalutamide derivatives as androgen receptor antagonistsSahar Kandil, Kok Yung Lee, Laurie Davies, et al.Pageof 9